InvestorsHub Logo
Followers 6
Posts 1923
Boards Moderated 0
Alias Born 03/15/2006

Re: Capt Bob post# 17269

Friday, 02/23/2007 7:28:53 AM

Friday, February 23, 2007 7:28:53 AM

Post# of 29237
Capt Bob, I sent most of your posts to the Medify investor line and this was the response that I received:

Dear Tom



As I know I follow the board on Ihub, and, in the circumstances, am a little disappointed after reading the post from “Capt. Bob”’.



The individual posted as Capt Bob contacted me to say inform me that his contact at IBM had found out the there was nothing viable about the company in the UK. This was a little surprising as we are in bi-weekly contact with a senior IBM UK executive, who is fully aware of the company.



I invited Bob to send his representative to contact me (I gave him my numbers), and then come to the office so that I could show him everything we are doing, along with current customer contacts so that his representative could speak to paying customers and agree we have a viable live product. This offer was initially accepted and then declined. He sent an email a day later saying that his guys (field service engineers) had completed a detailed report and done all the legwork and found out there was nothing available information wise. Bob said that he was going to sell his shares that day and then not comment any further.



Having extended the invitation I am more than a little disappointed. It is yet another instance of the company trying to openly extend information and having it used for a negative attack in an anonymous public forum.



If you would copies of the email traffic surrounding this conversation I would be more than happy to supply them.


In addition, I would like to thank Capt Bob for his comments on my previous role, and advise him to look under “sense of humour” on Wikipedia. We had one of those when we worked in the highest level of motorcycle sport in the UK. I notice he has neglected to mention that everyone else’s profile in that list is written with a humourous angle.



On top of this, Bob than asked if his mate, who had done the investigation, could drop into the office to talk about motorbikes!


Furthermore, whilst I am writing to you, please let me address the questions posed in Captain Bob’s insightful email.:



1) Ask them why they are filing a 15c211.

There are two options with a 15c211. The first is to post it on the pink sheets, as nothing more than an information point. The second is to file it, via US legal counsel, with the NASD. This is the route we are currently taking. Filing means that we will have a fully reporting company, with audited accounts, full disclosure on all share transactions etc. Additionally, we can recruit a Market Maker Sponsor. For the first 30 days after filing the 15c211 the Market Maker Sponsor has exclusivity for 30 days, allowing the PPS to recover.

2) Ask them about Oracle, Vodafone, Dextra, EMIS and the article in the Sentinel.
What would you like to know? I have a meeting on Monday with Business Intelligence Direct, part of Oracle’s salesforce and lead generation. Vodafone, I’ll update you as soon as I have the answers I am chasing. I was promised that the Certified Partner list would be updated four weeks from our approval, and it hasn’t been. I’ve chased it and am waiting for an answer. Dextra? Sell mobile phones and airtime contracts for us. Not MedifyRemote. EMIS. We’re just finalizing the latest software update with them. The Sentinel? It’s a newspaper. They saw a release from Dextra and did some research and wrote a story on us. Newspapers do that.

3) Ask them who the MM is?
No problems telling you that, once the contracts are signed and the 15c211 is approved by the NASD.



With Best Regards



Nik



Nik Ellwood

Head of Sales and Marketing

Medify Solutions Limited

Email: nellwood@medifysolutions.com

Web: www.medifysolutions.com


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.